Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects

NCT02054754 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
Pharmacokinetics
Cancer

Interventions

DRUG: Dexanabinol Dose Level 1
DRUG: Dexanabinol Dose Level 2
DRUG: Dexanabinol Dose Level 3
DRUG: Dexanabinol Dose Level 4
DRUG: Dexanabinol Dose Level 5
DRUG: Placebo

Sponsor

e-Therapeutics PLC